[Erectile disfunction and benign prostatic hyperplasia - causal relation or coincidence?].
There is increasing evidence of causal relation between benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). BPH appears to have a negative impact on sexual function. Drugs commonly used for the treatment of BPH (i.e. alphablockers, 5-alpha reductase inhibitors) may cause retrograde ejaculation, ED and reduced libido. Physicians should be aware of these adverse events and inform their patients accordingly. Conversely, phosphodiestease-5-inhibitors may have a beneficial effect on BPH symptoms.
Gasser
Thomas
T
Urologische Universitätsklinik Basel-Liestal, Kantonsspital Liestal, Liestal.
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D015984:Causality; D015897:Comorbidity; D007172:Erectile Dysfunction / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors
Sexualfunktionsstörungen und benigne Prostatahyperplasie - ursächlicher Zusammenhang oder Koinzidenz?